APA (7th ed.) Citation

Qianyi, W., Mei, X., Rui, Z., Yong, W., Yutao, W., Xiaoding, S., & Xiaoting, W. (2022). Delayed adjuvant imatinib in patients with high risk of recurrence of gastrointestinal stromal tumor after radical surgery: A retrospective cohort study. Journal of cancer research and clinical oncology, 148(6), 1493-1500. https://doi.org/10.1007/s00432-021-03749-6

Chicago Style (17th ed.) Citation

Qianyi, Wan, Xu Mei, Zhao Rui, Wang Yong, Wu Yutao, Shen Xiaoding, and Wu Xiaoting. "Delayed Adjuvant Imatinib in Patients with High Risk of Recurrence of Gastrointestinal Stromal Tumor After Radical Surgery: A Retrospective Cohort Study." Journal of Cancer Research and Clinical Oncology 148, no. 6 (2022): 1493-1500. https://doi.org/10.1007/s00432-021-03749-6.

MLA (9th ed.) Citation

Qianyi, Wan, et al. "Delayed Adjuvant Imatinib in Patients with High Risk of Recurrence of Gastrointestinal Stromal Tumor After Radical Surgery: A Retrospective Cohort Study." Journal of Cancer Research and Clinical Oncology, vol. 148, no. 6, 2022, pp. 1493-1500, https://doi.org/10.1007/s00432-021-03749-6.